Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

NCT04832971 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Mixed Dyslipidemia

Interventions

DRUG: ARO-ANG3
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals